Clinical Trial Update: Safety of an HIV Vaccine (AVX101) in HIV Uninfected Volunteers in the United States and South Africa [Phase 1]

View source ↗

Summary

This Phase 1 trial assessed the safety and tolerability of the AVX101 HIV vaccine in HIV-uninfected volunteers in the United States and South Africa; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• AVX101

Snippet

Sponsor: AlphaVax, Inc. | Conditions: HIV Infections | Phase 1 | Status: COMPLETED